194 Drug Samples Fail Quality Tests, CDSCO Flags 4 as Spurious in February Review
Central Drugs Standard Control Organisation has identified 194 drug samples as “Not of Standard Quality” (NSQ) during its routine monthly surveillance for February 2026, while four additional samples have been flagged as spurious.
Central Drugs Standard Control Organisation | 24/03/2026 | By Darshana | 123
India’s drug regulator Central Drugs Standard Control Organisation warns pharmaceutical firms against direct or indirect promotion of prescription-only GLP-1 drugs for obesity, stressing strict compliance with the Drugs and Cosmetics Act, 1940.
Central Drugs Standard Control Organisation | 13/03/2026 | By News Bureau
ACC Extends Dr Rajeev Singh Raghuvanshi's appointment as Drugs Controller (India) for One Year
Dr Rajeev Singh Raghuvanshi receives a second one-year extension as head of CDSCO amid ongoing regulatory reforms and Schedule M implementation.
Central Drugs Standard Control Organisation | 02/03/2026 | By News Bureau | 332
CDSCO to Outsource GMP Audits and Add 1,500 Experts to Boost Scientific Oversight
Central Drugs Standard Control Organisation has announced plans to strengthen its regulatory framework by outsourcing Good Manufacturing Practice (GMP) audits to accredited third-party agencies and expanding its scientific workforce by approximately 1,500 experts.
Central Drugs Standard Control Organisation | 24/02/2026 | By Darshana | 201
India, Brazil Ink MoU to Deepen Regulatory Cooperation in Pharma and Medical Products
India’s CDSCO and Brazil’s ANVISA exchanged MoU in the presence of Prime Minister Narendra Modi and President Luiz Inácio Lula da Silva to strengthen regulatory cooperation in pharmaceuticals and medical products.
Central Drugs Standard Control Organisation | 23/02/2026 | By News Bureau
CDSCO Flags 240 Drug Samples as Not of Standard Quality in January 2026
Central Drugs Standard Control Organisation has reported that 240 drug samples tested across India in January 2026 were found to be Not of Standard Quality (NSQ). Of these, 68 samples were identified by Central Drugs Laboratories, while 172 were flagged by State Drugs Testing Laboratories.
Central Drugs Standard Control Organisation | 23/02/2026 | By Darshana | 488
CDSCO Flags 167 Drug Samples as Substandard, Seven Found Spurious
India’s drug regulator has identified 167 medicine samples that failed quality tests and classified seven additional samples as spurious during routine surveillance conducted in December. The findings were released as part of the Central Drugs Standard Control Organisation’s (CDSCO) monthly drug alert.
Central Drugs Standard Control Organisation | 22/01/2026 | By Darshana | 169
CDSCO Flags 205 Not of Standard Quality Drug Samples in November Despite Data Gaps from States
Even as data submissions were pending from nearly 18 states and five Union Territories, the Central Drugs Standard Control Organisation (CDSCO) reported a total of 205 drug samples as Not of Standard Quality (NSQ) during November 2025.
Central Drugs Standard Control Organisation | 26/12/2025 | By Darshana | 287
CDSCO Mandates Online Submission of CGTP Clinical Trial Applications via SUGAM Portal
For now on, offline submissions of clinical trial applications for Cell and Gene Therapy Products (CGTPs) will not be accepted by the CDSCO.
Central Drugs Standard Control Organisation | 11/07/2025 | By Dineshwori | 339
NRA Meets WHO International Standards for Vaccine Regulations
WHO has established global standards and benchmarks for assurance of vaccine quality through the development of tools and guidelines, benchmarking of the NRA and prequalification programme of vaccines.
Central Drugs Standard Control Organisation | 14/10/2024 | By Aishwarya | 715
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy